Good morning, investor! We’re starting off Tuesday with a breakdown of the biggest pre-market stock movers!
Source: f11photo/Shutterstock.com
News from the FDA, earnings reports, Omicron concerns, and more are behind today’s early morning stock movement.
Let’s dive into that news below!
Pre-Market Stock Movers: 10 Top Gainers
- Cumberland (NASDAQ:CPIX) stock is rocketing more than 87% .
- Erytech Pharma (NASDAQ:ERYP) shares are soaring over 46% .
- Pioneer Power Solutions (NASDAQ:PPSI) stock is gaining more than 39% .
- Immunogen (NASDAQ:IMGN) shares are rising over 39% .
- Athersys (NASDAQ:ATHX) stock is increasing more than 27% .
- Allied Healthcare (NASDAQ:AHPI) shares are sitting 26% higher .
- Vir Biotechnology (NASDAQ:VIR) stock is climbing over 16% .
- IO Biotech (NASDAQ:IOBT) shares are getting a more than 14% boost .
- Quhuo (NASDAQ:QH) stock is jumping over 12% .
- Molecular Partners (NASDAQ:MOLN) shares are up more than 12% .
10 Top Losers
- Biophytis (NASDAQ:BPTS) stock is plummeting over 26% after shares rallied higher on Monday.
- Array Technologies (NASDAQ:ARRY) shares are diving more than 10% .
- ProShares Ultra Bloomberg Natural Gas (NYSEARCA:BOIL) stock is taking an over 10% beating in pre-market trading today.
- Avenue Therapeutics (NASDAQ:ATXI) shares are falling 10% .
- Palatin Technologies (NYSEAMERICAN:PTN) stock is pulling back more than 9% as shares drop after a price target boost last week.
- cbdMD (NYSEAMERICAN:YCBD) shares are retreating over 9% after a deal sent them higher on Monday.
- Micro Focus International (NYSE:MFGP) stock is dropping roughly 9% as it continues recent negative movement.
- JinkoSolar Holding Co (NYSE:JKS) shares are decreasing close to 9% .
- Lizhi (NASDAQ:LIZI) stock is slipping more than 8% .
- BioNTech (NASDAQ:BNTX) shares close out our pre-market stock movers down over 7% .
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
